1 / 26

NCN Prostate Core Biopsy Reporting Audit

NCN Prostate Core Biopsy Reporting Audit. Dr Ursula Earl NCN Histopath SSG Audit Lead. Methodology. Lab managers asked to complete a datasheet 4 questions One side of A4. Lab Managers’ Data Sheet. Number of cases received between Oct 1 st to Dec 31 st 2013

markku
Download Presentation

NCN Prostate Core Biopsy Reporting Audit

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NCN Prostate Core Biopsy Reporting Audit Dr Ursula Earl NCN Histopath SSG Audit Lead

  2. Methodology • Lab managers asked to complete a datasheet • 4 questions • One side of A4

  3. Lab Managers’ Data Sheet • Number of cases received between Oct 1st to Dec 31st 2013 • Histological diagnosis by % type using specific (RCPath) SNOMED code search • Turnaround time from date of biopsy taken to date of report authorisation • % of cases with immunohistochemistry

  4. Standards – Final diagnosis • % of cases in four diagnostic categories (malignant, benign, high grade PIN, suspicious) • Re-audit of TRUS prostate biopsy reporting in West Kent comparing data from two trusts with Ontario 2010 data (Bulletin of RCPath April 2012, 158, 95-100)

  5. Standards – Turnaround Times • RCPath KPI 6.4 – 80% of cases reported within 7 calendar days, 90% of cases reported within 10 calendar days of biopsy/procedure • NHS Improvement: Learning how to achieve a seven day turnaround time in histopathology

  6. Number of cases received • NCN Trust Range 93-200 • Kent – figures supplied for a 10 month period March – Dec 2010 for Trust A, Trust B & Trusts A & B combined) • Kent A - 136.5 in 3 month period • Kent B - 43.8 in 3 month period • Kent A&B - 233 in 3 month period

  7. Histological diagnosis – SNOMED codes • Adenocarcinoma (M81403) • High grade PIN (M81402) • Suspicious (M69760, M69700) • Benign (M09450, M09460, M40000, M72000 etc)

  8. % of cases by diagnostic category

  9. Adenocarcinoma Diagnosis • NCN Range - 40 – 62% • Kent combined - 52.2% • Kent A – 55.6% • Kent B – 47.2% • Ontario – 47%

  10. Kent A Ontario

  11. % of cases high grade PIN or suspicious

  12. Benign Diagnosis • NCN range - 34.5 – 47.3% • Kent A – 36.7% • Kent B - 45.6% • Kent com - 40.3% • Ontario – 40%

  13. % of cases with benign diagnosis Kent A

  14. Use of IHC • NCN range - 27% to 82% • Kent comb - 30% • Kent A – 33% • Kent B - 25%

  15. % of cases with IHC

  16. Turnaround Time • KPI 6.4 • 90% of cases reported within 10 calendar days • 80% of cases reported within 7 calendar days • NHS IMPROVEMENT • 7 day reporting TAT

  17. TAT - Methodology • Some trusts struggled to provide this data because of limitations of their lab computer systems & separation of prostatic core biopsy samples from other prostate specimens

  18. Achieving a 7 day TAT

  19. Achieving a 90% 10 day TAT

  20. Summary - TAT • All trusts meeting the RCPath KPI 6.4 standard of 80% of cases reported within 7 calendar days • 6 of 7 trusts meeting the RCPath KPI 6.4 standard of 90% of cases reported within 10 calendar days • No trust met NHS Improvement target of 100%, 7 day turnaround

  21. Questions? • Variable use of IHC between trusts • Use of suspicious as a diagnostic category • Data recording & retrieval on lab computer systems, is Pathosysfullfilling all the audit functions?

  22. Action Plan • Present findings at NCN Histopath Audit meeting at Evolve, June 10th 2014 • Send presentation to participating pathologists & lab managers. • Individual departments to review their figures & compare with other trusts • Root cause analysis if significant discrepancies flagged

  23. Acknowledgements & Thanks Peter Booth, Trudy Johnson, Derek Pace Jacqui Richards, Sharron Williams, IanTaylor,, Phil Gibson, Adrienne Mutton, Paul Barrett, Muhammad Siddiqui, Matthew Theodosiou, Diane Hemming, Bob Stirling, Amira El Sharif, Sri Nagarajan

More Related